Circulating Small Cell Lung Cancer Cells Successfully Cultivated For The Very First Time

Circulating Small Cell Lung Cancer Cells Successfully Cultivated For The Very First Time

Article
Healthy Lungs
Health & Wellness
+2
Contributed byKrish Tangella MD, MBAJul 08, 2016

Most cases of small cell lung cancer are only diagnosed after the tumour has already formed metastases. Until now it has not been possible to investigate the reasons for this rapid metastasis, because of a lack of sufficient tumour material from patients. Now, the group of researchers led by Gerhard Hamilton, University Department of Surgery at Medical University of Vienna has succeeded in creating infinitely reproducing tissue cultures. The findings have been published in the leading journal OncoImmunology.

Every year around 4,000 people in Austria die of lung cancer, approximately 90% of whom have smoked heavily for many decades. This malignant disease is becoming increasingly prevalent among women in particular, so that now lung cancer has outstripped breast cancer as the most common cause of death from cancer in women. 15% of lung cancer patients have "small cell lung cancer" (SCLC), which in most cases has already formed metastases at the time of diagnosis so that the prognosis is correspondingly poor. The treatment consists of cytotoxic chemotherapy and irradiation. At this stage, an operation would not be effective and is therefore not performed.

Initially most patients respond very well to the combination treatment. However, within about a year tumors recur and these are resistant to further chemotherapy treatments so that the patient's chances of survival are drastically reduced. Until now it has not been possible to investigate why this cancer behaves so aggressively because, since only small biopsies are collected, there is not enough cell material available for biomolecular analysis. The only starting point was the knowledge that SCLC patients had a very high number of circulating tumor cells in their blood.

The group led by Gerhard Hamilton, in collaboration with Robert Zeillinger (Molecular Oncology Group, University Department of Obstetrics and Gynecology) and Maximilian Hochmair (Otto-Wagner Hospital), have now managed to establish a method for permanently cultivating the circulating tumour cells from patients with advanced small cell lung cancer. The researchers were able to use this method to develop four cell lines that are able to propagate indefinitely.

This enabled them to describe how the tumor cells managed to manipulate the body's immune system. Monocytes are developed into macrophages and then chemical messenger substances change their polarity so that, instead of fighting tumor cells, they create an inflammatory micro-environment, which further stimulates the spread of cancer cells. There are also indications that chronic obstructive lung disease (COPD) was already present in the main patient risk group prior to the onset of lung cancer and this also favoured the formation of circulating tumor cells.

This completely new finding has now been published in the leading journalOncoImmunology and goes a long way towards explaining tumor metastasis, possibly with relevance for other malignancies as well. The next goal set by Hamilton's research group is to find out why the recurrent SCLC tumors are resistant to chemotherapy.


The above post is a redistributed news release provided by Medical University of Vienna. Note: Materials may be edited for content and length. 

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Hamilton, G., Rath, B., Klameth, L., & Hochmair, M. J. (2015). Small cell lung cancer: recruitment of macrophages by circulating tumor cells.OncoImmunology, (just-accepted), 00-00. 

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!